Survivorship - Introductory Lectures
With more than 12 million cancer survivors in the United States, there is a growing need for cancer survivorship management. Lewis E. Foxhall, Vice President of Health Policy and Professor of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center says the number of cancer survivors will continue to grow thanks to improvements in treatment and changes in the availability of screening and prevention interventions. In his lecture, "Cancer Survivorship Management for Health Care Professionals," Dr. Foxhall breaks down the types of cancer survivors and the duration of their survival. He gives an overview for the risk of recurrence, the risk of developing a second primary cancer, and discusses late effects from treatment cancer survivors might face. Dr. Foxhall also explains why prevention and health promotion is a critical part of care for cancer survivors.
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Cancer Survivorship Management for Health Care Professionals
Presenter: Lewis E. Foxhall, M.D.
Vice President, Health Policy
Office of the Executive Vice President, Physician in Chief
Professor, Department of Clinical Cancer Prevention
Summary: Dr. Lewis Foxhall, Vice President of Health Policy at The University of Texas MD Anderson Cancer Center, presents the lecture, "Cancer Survivorship Management for Health Care Professionals." As the number of cancer survivors in the United States approaches 12 million, Dr. Foxhall emphasizes the importance of optimizing the benefits of cancer treatment while also maximizing the patient’s quality of life and duration of their survivorship. Recognizing that a diagnosis of cancer may shift medical attention away from important health issues not related to cancer, cancer survivors are also significantly less likely to receive prevention and appropriate screening for tumor recurrence, second tumors, and co-morbid conditions. Cancer survivors are also less likely to be afforded effective management of late and long-term effects of cancer treatment upon returning to the primary care setting. Thus, it is important for primary care physicians to be familiar with current management recommendations for cancer survivors. Dr. Foxhall discusses the particular health risks that threaten cancer survivors and provides recommendations for medical management of survivors who comprise a diverse population of patients with various health needs. In his lecture, Dr. Foxhall discusses long-term and late effects of cancer treatment. Dr. Foxhall also reviews common symptoms of cancer recurrence and guidelines for management of breast, colorectal and prostate cancer survivors.
Summary and Learning Objectives: Español
Summary: It may be surprising, but second primary cancers are the fifth most common type of cancer and account for about 10 percent of all cancers that are diagnosed. Not only that, but as the number of cancer survivors increases, the incidence of second primary cancers increases. Dr. Therese Bevers, Medical Director of Cancer Prevention and Professor of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center says "Fourteen percent of cancer patients will develop a second primary cancer by 25 years of follow-up." In her lecture, "Cancer Survivorship: Introduction to Second Primary Cancers," Dr. Bevers defines second primary cancer, reviews their incidence, and outlines three common carcinogenic pathways for the development of a second primary cancer. She also discusses ways to reduce the risk of developing second primary cancers and how to best screen for them.
For further information or assistance, to provide feedback on this web site, or to request a specific professional oncology education topic, please e-mail Professional Oncology Education.